Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Bristol Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Sussex Featured PhD Programmes
University of Oxford Featured PhD Programmes
Max Planck Society Featured PhD Programmes
"immunotherapy"×
10 miles

immunotherapy PhD Projects, Programs & Scholarships

We have 31 immunotherapy PhD Projects, Programs & Scholarships

  • "immunotherapy" ×
  • clear all
Order by 
Showing 1 to 10 of 31
  MRC DiMeN Doctoral Training Partnership: Rationally Designed Oncolytic Reovirus-Based Immunotherapy for Hepatocellular Carcinoma
  Dr A Samson, Prof A Whitehouse, Dr C McKimmie
Application Deadline: 21 January 2019
Background. The incidence of hepatocellular carcinoma (HCC) in the UK has increased more than four-fold since 1990, and worldwide HCC is the second biggest cause of cancer-specific mortality.
  How an IFNγ target gene mediates resistance to immunotherapy
  Dr A Hurlstone, Prof K Williams, Dr J Bruce
Applications accepted all year round
Metastatic melanoma, a highly aggressive form of skin cancer, can respond well to immunotherapy with immune checkpoint inhibitors, but there are still a significant proportion of patients not benefitting or for whom benefits are not durable.
  A pilot study of oral immunotherapy as a treatment to desensitise horses with insect bite hypersensitivity to Culicoides spp
  Dr AD Wilson
Applications accepted all year round
The project. Equine Insect Bite Hypersensitivity (IBH) is a Type I IgE-mediated allergy of horses to salivary proteins of Culicoides spp.
  Defining the role of p53 in cancer immunotherapy
  Prof Y. Haupt, Dr S. Haupt, Dr P. Neeson
Applications accepted all year round
Despite clear evidence of an association between the tumour suppressor p53 and immunity, a gap in knowledge exists regarding its role in modulating immune responses, or its value in predicting patient responses to immunotherapy.
  Machine Learning and Integrative Approaches in Immunology: Developing machine-learning and mathematical models to understand heterogeneity of response to personalised cancer immunotherapy
  Dr H Koohy, Prof V Cerundolo, Prof T Dong, Prof A Simmons
Application Deadline: 11 January 2019
Cancer immunology is an area of cancer research that is gaining tremendous momentum. However, responses to immunotherapy are heterogeneous and patient care could be substantially improved by better understanding of how and why responses to immunotherapeutic approaches vary in different patients.
  Delineating transcriptional pathways that limit anti-cancer T cell function
  Dr I Parish
Applications accepted all year round
During cancer growth, cytotoxic T cells that would normally kill cancer cells lose their function in a process called exhaustion.
  T Cell Biology: Studying how lymphocytes decide to mount immune responses against, for example, tumours (cancer immunotherapy).
  Prof S Davis
Application Deadline: 11 January 2019
Studying how lymphocytes decide to mount immune responses against, for example, tumours (cancer immunotherapy).
  Resurrecting ancestral human sugars: a novel ‘molecular archaeology’ approach to cancer immunotherapy using chemical bioconjugation
  Dr M A Fascione, Prof G Davies, Prof J Southgate
Application Deadline: 9 January 2019
Background. Human cells surfaces are coated in a thick layer of sticky sugars called the glycocalyx. The composition of this coating is dynamic and changes depending on cell type and function.
  Examining the Potential of C-type Lectin-like Receptors (CLRs) as Immunotherapy Targets
  Research Group: Centre for Experimental Medicine
  Dr S Orr
Application Deadline: 20 January 2019
Invasive fungal infections kill more people per year than TB or malaria. Immunosuppressed patients (cancer patients undergoing chemotherapy, acute myeloid leukaemia, HIV, bone marrow transplant patients) are at high risk of developing invasive fungal infections.
  Defining targets modulating anti-tumour immune effectors in vivo
  Dr E Roberts
Application Deadline: 11 January 2019
The Cancer Research UK Beatson Institute in Glasgow is one of the world-leading centres for cancer research. The Institute provides an outstanding research environment, underpinned by state-of-the-art core services and advanced technologies with special emphasis on imaging, metabolomics and in vivo models of cancer.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.